Global Alzheimer's Disease Drug Market Insights and Forecast to 2028

Q: How big is the alzheimers disease drug market?

It is the cause of 60 to 70 of cases of dementia.Market Analysis and Insights Global Alzheimers Disease Drug MarketDue to the COVID19 pandemic the global Alzheimers Disease Drug market size is estimated to be worth US 3676.9 million in 2022 and is forecast to a readjusted size of US 4020.5 million by 2028 with a CAGR of 1.5 during the review period.

Q: Who are the key players in the alzheimers disease drug market?

Some of the key players are Novartis, Novartis AG, Eisai Co Ltd, Allergan plc, Allergan, Allergan, Daiichi Sankyo, Merz Pharma, Pfizer Inc, Johnson & Johnson, Lundbeck, Russia, China, Companies, Companies, Companies, Market Participants, Companies, Key, Others.

Code: QYRE-Auto-1529

Report

January 2022

Pages:91

QYResearch

Description

Table of Content

Tables & Figures

FEATURED COMPANIES

Alzheimer's disease (AD), also referred to simply as Alzheimer's, is a chronic neurodegenerative disease that usually starts slowly and worsens over time. It is the cause of 60% to 70% of cases of dementia.

Market Analysis and Insights: Global Alzheimer's Disease Drug Market

Due to the COVID-19 pandemic, the global Alzheimer's Disease Drug market size is estimated to be worth US$ 3676.9 million in 2022 and is forecast to a readjusted size of US$ 4020.5 million by 2028 with a CAGR of 1.5% during the review period.

Fully considering the economic change by this health crisis, Donepezil accounting for % of the Alzheimer's Disease Drug global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period.

While Early to Moderate Stages segment is altered to an % CAGR throughout this forecast period.

The major players in global Alzheimer’s Disease Drug market include Allergan, Eisai, Novartis, Daiichi Sankyo, Merz Pharma, Pfizer, Johnson & Johnson, Lundbeck, etc. The top 3 players hold over 60% of global shares. Europe and North America are main markets, they occupy over 70% of the global market. Memantine and Donepezil are the main types, with a share about 70%. Early to Moderate Stages is the key application, which covers over 55% shares.

Global Alzheimer's Disease Drug Scope and Segment

Alzheimer's Disease Drug market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Alzheimer's Disease Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

Donepezil

Memantine

Rivastigmine

Others

Segment by Application

Early to Moderate Stages

Moderate to Severe Stages

BY COMPANY

Allergan

Eisai

Novartis

Daiichi Sankyo

Merz Pharma

Pfizer

Johnson & Johnson

Lundbeck

BY REGION

North America

U.S.

Canada

Europe

Germany

France

U.K.

Italy

Russia

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Indonesia

Thailand

Malaysia

Latin America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

FEATURED COMPANIES

1 Study Coverage

1.1 Alzheimer's Disease Drug Product Introduction

1.2 Market by Type

1.2.1 Global Alzheimer's Disease Drug Market Size Growth Rate by Type, 2017 VS 2021 VS 2028

1.2.2 Donepezil

1.2.3 Memantine

1.2.4 Rivastigmine

1.2.5 Others

1.3 Market by Application

1.3.1 Global Alzheimer's Disease Drug Market Size Growth Rate by Application, 2017 VS 2021 VS 2028

1.3.2 Early to Moderate Stages

1.3.3 Moderate to Severe Stages

1.4 Study Objectives

1.5 Years Considered

2 Executive Summary

2.1 Global Alzheimer's Disease Drug Sales Estimates and Forecasts 2017-2028

2.2 Global Alzheimer's Disease Drug Revenue Estimates and Forecasts 2017-2028

2.3 Global Alzheimer's Disease Drug Revenue by Region: 2017 VS 2021 VS 2028

2.4 Global Alzheimer's Disease Drug Sales by Region

2.4.1 Global Alzheimer's Disease Drug Sales by Region (2017-2022)

2.4.2 Global Sales Alzheimer's Disease Drug by Region (2023-2028)

2.5 Global Alzheimer's Disease Drug Revenue by Region

2.5.1 Global Alzheimer's Disease Drug Revenue by Region (2017-2022)

2.5.2 Global Alzheimer's Disease Drug Revenue by Region (2023-2028)

2.6 North America

2.7 Europe

2.8 Asia-Pacific

2.9 Latin America

2.10 Middle East & Africa

3 Competition by Manufacturers

3.1 Global Alzheimer's Disease Drug Sales by Manufacturers

3.1.1 Global Top Alzheimer's Disease Drug Manufacturers by Sales (2017-2022)

3.1.2 Global Alzheimer's Disease Drug Sales Market Share by Manufacturers (2017-2022)

3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Alzheimer's Disease Drug in 2021

3.2 Global Alzheimer's Disease Drug Revenue by Manufacturers

3.2.1 Global Alzheimer's Disease Drug Revenue by Manufacturers (2017-2022)

3.2.2 Global Alzheimer's Disease Drug Revenue Market Share by Manufacturers (2017-2022)

3.2.3 Global Top 10 and Top 5 Companies by Alzheimer's Disease Drug Revenue in 2021

3.3 Global Alzheimer's Disease Drug Sales Price by Manufacturers (2017-2022)

3.4 Analysis of Competitive Landscape

3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Alzheimer's Disease Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.4.3 Global Alzheimer's Disease Drug Manufacturers Geographical Distribution

3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

4.1 Global Alzheimer's Disease Drug Sales by Type

4.1.1 Global Alzheimer's Disease Drug Historical Sales by Type (2017-2022)

4.1.2 Global Alzheimer's Disease Drug Forecasted Sales by Type (2023-2028)

4.1.3 Global Alzheimer's Disease Drug Sales Market Share by Type (2017-2028)

4.2 Global Alzheimer's Disease Drug Revenue by Type

4.2.1 Global Alzheimer's Disease Drug Historical Revenue by Type (2017-2022)

4.2.2 Global Alzheimer's Disease Drug Forecasted Revenue by Type (2023-2028)

4.2.3 Global Alzheimer's Disease Drug Revenue Market Share by Type (2017-2028)

4.3 Global Alzheimer's Disease Drug Price by Type

4.3.1 Global Alzheimer's Disease Drug Price by Type (2017-2022)

4.3.2 Global Alzheimer's Disease Drug Price Forecast by Type (2023-2028)

5 Market Size by Application

5.1 Global Alzheimer's Disease Drug Sales by Application

5.1.1 Global Alzheimer's Disease Drug Historical Sales by Application (2017-2022)

5.1.2 Global Alzheimer's Disease Drug Forecasted Sales by Application (2023-2028)

5.1.3 Global Alzheimer's Disease Drug Sales Market Share by Application (2017-2028)

5.2 Global Alzheimer's Disease Drug Revenue by Application

5.2.1 Global Alzheimer's Disease Drug Historical Revenue by Application (2017-2022)

5.2.2 Global Alzheimer's Disease Drug Forecasted Revenue by Application (2023-2028)

5.2.3 Global Alzheimer's Disease Drug Revenue Market Share by Application (2017-2028)

5.3 Global Alzheimer's Disease Drug Price by Application

5.3.1 Global Alzheimer's Disease Drug Price by Application (2017-2022)

5.3.2 Global Alzheimer's Disease Drug Price Forecast by Application (2023-2028)

6 North America

6.1 North America Alzheimer's Disease Drug Market Size by Type

6.1.1 North America Alzheimer's Disease Drug Sales by Type (2017-2028)

6.1.2 North America Alzheimer's Disease Drug Revenue by Type (2017-2028)

6.2 North America Alzheimer's Disease Drug Market Size by Application

6.2.1 North America Alzheimer's Disease Drug Sales by Application (2017-2028)

6.2.2 North America Alzheimer's Disease Drug Revenue by Application (2017-2028)

6.3 North America Alzheimer's Disease Drug Market Size by Country

6.3.1 North America Alzheimer's Disease Drug Sales by Country (2017-2028)

6.3.2 North America Alzheimer's Disease Drug Revenue by Country (2017-2028)

6.3.3 U.S.

6.3.4 Canada

7 Europe

7.1 Europe Alzheimer's Disease Drug Market Size by Type

7.1.1 Europe Alzheimer's Disease Drug Sales by Type (2017-2028)

7.1.2 Europe Alzheimer's Disease Drug Revenue by Type (2017-2028)

7.2 Europe Alzheimer's Disease Drug Market Size by Application

7.2.1 Europe Alzheimer's Disease Drug Sales by Application (2017-2028)

7.2.2 Europe Alzheimer's Disease Drug Revenue by Application (2017-2028)

7.3 Europe Alzheimer's Disease Drug Market Size by Country

7.3.1 Europe Alzheimer's Disease Drug Sales by Country (2017-2028)

7.3.2 Europe Alzheimer's Disease Drug Revenue by Country (2017-2028)

7.3.3 Germany

7.3.4 France

7.3.5 U.K.

7.3.6 Italy

7.3.7 Russia

8 Asia Pacific

8.1 Asia Pacific Alzheimer's Disease Drug Market Size by Type

8.1.1 Asia Pacific Alzheimer's Disease Drug Sales by Type (2017-2028)

8.1.2 Asia Pacific Alzheimer's Disease Drug Revenue by Type (2017-2028)

8.2 Asia Pacific Alzheimer's Disease Drug Market Size by Application

8.2.1 Asia Pacific Alzheimer's Disease Drug Sales by Application (2017-2028)

8.2.2 Asia Pacific Alzheimer's Disease Drug Revenue by Application (2017-2028)

8.3 Asia Pacific Alzheimer's Disease Drug Market Size by Region

8.3.1 Asia Pacific Alzheimer's Disease Drug Sales by Region (2017-2028)

8.3.2 Asia Pacific Alzheimer's Disease Drug Revenue by Region (2017-2028)

8.3.3 China

8.3.4 Japan

8.3.5 South Korea

8.3.6 India

8.3.7 Australia

8.3.8 China Taiwan

8.3.9 Indonesia

8.3.10 Thailand

8.3.11 Malaysia

9 Latin America

9.1 Latin America Alzheimer's Disease Drug Market Size by Type

9.1.1 Latin America Alzheimer's Disease Drug Sales by Type (2017-2028)

9.1.2 Latin America Alzheimer's Disease Drug Revenue by Type (2017-2028)

9.2 Latin America Alzheimer's Disease Drug Market Size by Application

9.2.1 Latin America Alzheimer's Disease Drug Sales by Application (2017-2028)

9.2.2 Latin America Alzheimer's Disease Drug Revenue by Application (2017-2028)

9.3 Latin America Alzheimer's Disease Drug Market Size by Country

9.3.1 Latin America Alzheimer's Disease Drug Sales by Country (2017-2028)

9.3.2 Latin America Alzheimer's Disease Drug Revenue by Country (2017-2028)

9.3.3 Mexico

9.3.4 Brazil

9.3.5 Argentina

9.3.6 Colombia

10 Middle East and Africa

10.1 Middle East and Africa Alzheimer's Disease Drug Market Size by Type

10.1.1 Middle East and Africa Alzheimer's Disease Drug Sales by Type (2017-2028)

10.1.2 Middle East and Africa Alzheimer's Disease Drug Revenue by Type (2017-2028)

10.2 Middle East and Africa Alzheimer's Disease Drug Market Size by Application

10.2.1 Middle East and Africa Alzheimer's Disease Drug Sales by Application (2017-2028)

10.2.2 Middle East and Africa Alzheimer's Disease Drug Revenue by Application (2017-2028)

10.3 Middle East and Africa Alzheimer's Disease Drug Market Size by Country

10.3.1 Middle East and Africa Alzheimer's Disease Drug Sales by Country (2017-2028)

10.3.2 Middle East and Africa Alzheimer's Disease Drug Revenue by Country (2017-2028)

10.3.3 Turkey

10.3.4 Saudi Arabia

11 Company Profiles

11.1 Allergan

11.1.1 Allergan Corporation Information

11.1.2 Allergan Overview

11.1.3 Allergan Alzheimer's Disease Drug Sales, Price, Revenue and Gross Margin (2017-2022)

11.1.4 Allergan Alzheimer's Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications

11.1.5 Allergan Recent Developments

11.2 Eisai

11.2.1 Eisai Corporation Information

11.2.2 Eisai Overview

11.2.3 Eisai Alzheimer's Disease Drug Sales, Price, Revenue and Gross Margin (2017-2022)

11.2.4 Eisai Alzheimer's Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications

11.2.5 Eisai Recent Developments

11.3 Novartis

11.3.1 Novartis Corporation Information

11.3.2 Novartis Overview

11.3.3 Novartis Alzheimer's Disease Drug Sales, Price, Revenue and Gross Margin (2017-2022)

11.3.4 Novartis Alzheimer's Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications

11.3.5 Novartis Recent Developments

11.4 Daiichi Sankyo

11.4.1 Daiichi Sankyo Corporation Information

11.4.2 Daiichi Sankyo Overview

11.4.3 Daiichi Sankyo Alzheimer's Disease Drug Sales, Price, Revenue and Gross Margin (2017-2022)

11.4.4 Daiichi Sankyo Alzheimer's Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications

11.4.5 Daiichi Sankyo Recent Developments

11.5 Merz Pharma

11.5.1 Merz Pharma Corporation Information

11.5.2 Merz Pharma Overview

11.5.3 Merz Pharma Alzheimer's Disease Drug Sales, Price, Revenue and Gross Margin (2017-2022)

11.5.4 Merz Pharma Alzheimer's Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications

11.5.5 Merz Pharma Recent Developments

11.6 Pfizer

11.6.1 Pfizer Corporation Information

11.6.2 Pfizer Overview

11.6.3 Pfizer Alzheimer's Disease Drug Sales, Price, Revenue and Gross Margin (2017-2022)

11.6.4 Pfizer Alzheimer's Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications

11.6.5 Pfizer Recent Developments

11.7 Johnson & Johnson

11.7.1 Johnson & Johnson Corporation Information

11.7.2 Johnson & Johnson Overview

11.7.3 Johnson & Johnson Alzheimer's Disease Drug Sales, Price, Revenue and Gross Margin (2017-2022)

11.7.4 Johnson & Johnson Alzheimer's Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications

11.7.5 Johnson & Johnson Recent Developments

11.8 Lundbeck

11.8.1 Lundbeck Corporation Information

11.8.2 Lundbeck Overview

11.8.3 Lundbeck Alzheimer's Disease Drug Sales, Price, Revenue and Gross Margin (2017-2022)

11.8.4 Lundbeck Alzheimer's Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications

11.8.5 Lundbeck Recent Developments

12 Industry Chain and Sales Channels Analysis

12.1 Alzheimer's Disease Drug Industry Chain Analysis

12.2 Alzheimer's Disease Drug Key Raw Materials

12.2.1 Key Raw Materials

12.2.2 Raw Materials Key Suppliers

12.3 Alzheimer's Disease Drug Production Mode & Process

12.4 Alzheimer's Disease Drug Sales and Marketing

12.4.1 Alzheimer's Disease Drug Sales Channels

12.4.2 Alzheimer's Disease Drug Distributors

12.5 Alzheimer's Disease Drug Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis

13.1 Alzheimer's Disease Drug Industry Trends

13.2 Alzheimer's Disease Drug Market Drivers

13.3 Alzheimer's Disease Drug Market Challenges

13.4 Alzheimer's Disease Drug Market Restraints

14 Key Findings in The Global Alzheimer's Disease Drug Study

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.2 Data Source

15.2 Author Details

15.3 Disclaimer

FEATURED COMPANIES

List of Tables

Table 1. Global Alzheimer's Disease Drug Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)

Table 2. Major Manufacturers of Donepezil

Table 3. Major Manufacturers of Memantine

Table 4. Major Manufacturers of Rivastigmine

Table 5. Major Manufacturers of Others

Table 6. Global Alzheimer's Disease Drug Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)

Table 7. Global Alzheimer's Disease Drug Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)

Table 8. Global Alzheimer's Disease Drug Sales by Region (2017-2022) & (M Units)

Table 9. Global Alzheimer's Disease Drug Sales Market Share by Region (2017-2022)

Table 10. Global Alzheimer's Disease Drug Sales by Region (2023-2028) & (M Units)

Table 11. Global Alzheimer's Disease Drug Sales Market Share by Region (2023-2028)

Table 12. Global Alzheimer's Disease Drug Revenue by Region (2017-2022) & (US$ Million)

Table 13. Global Alzheimer's Disease Drug Revenue Market Share by Region (2017-2022)

Table 14. Global Alzheimer's Disease Drug Revenue by Region (2023-2028) & (US$ Million)

Table 15. Global Alzheimer's Disease Drug Revenue Market Share by Region (2023-2028)

Table 16. Global Alzheimer's Disease Drug Sales by Manufacturers (2017-2022) & (M Units)

Table 17. Global Alzheimer's Disease Drug Sales Share by Manufacturers (2017-2022)

Table 18. Global Alzheimer's Disease Drug Revenue by Manufacturers (2017-2022) & (US$ Million)

Table 19. Global Alzheimer's Disease Drug Revenue Share by Manufacturers (2017-2022)

Table 20. Alzheimer's Disease Drug Price by Manufacturers (2017-2022) &(US$/Unit)

Table 21. Global Alzheimer's Disease Drug Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 22. Global Alzheimer's Disease Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Alzheimer's Disease Drug as of 2021)

Table 23. Alzheimer's Disease Drug Manufacturing Base Distribution and Headquarters

Table 24. Manufacturers Alzheimer's Disease Drug Product Offered

Table 25. Date of Manufacturers Enter into Alzheimer's Disease Drug Market

Table 26. Mergers & Acquisitions, Expansion Plans

Table 27. Global Alzheimer's Disease Drug Sales by Type (2017-2022) & (M Units)

Table 28. Global Alzheimer's Disease Drug Sales by Type (2023-2028) & (M Units)

Table 29. Global Alzheimer's Disease Drug Sales Share by Type (2017-2022)

Table 30. Global Alzheimer's Disease Drug Sales Share by Type (2023-2028)

Table 31. Global Alzheimer's Disease Drug Revenue by Type (2017-2022) & (US$ Million)

Table 32. Global Alzheimer's Disease Drug Revenue by Type (2023-2028) & (US$ Million)

Table 33. Global Alzheimer's Disease Drug Revenue Share by Type (2017-2022)

Table 34. Global Alzheimer's Disease Drug Revenue Share by Type (2023-2028)

Table 35. Alzheimer's Disease Drug Price by Type (2017-2022) & (US$/Unit)

Table 36. Global Alzheimer's Disease Drug Price Forecast by Type (2023-2028) & (US$/Unit)

Table 37. Global Alzheimer's Disease Drug Sales by Application (2017-2022) & (M Units)

Table 38. Global Alzheimer's Disease Drug Sales by Application (2023-2028) & (M Units)

Table 39. Global Alzheimer's Disease Drug Sales Share by Application (2017-2022)

Table 40. Global Alzheimer's Disease Drug Sales Share by Application (2023-2028)

Table 41. Global Alzheimer's Disease Drug Revenue by Application (2017-2022) & (US$ Million)

Table 42. Global Alzheimer's Disease Drug Revenue by Application (2023-2028) & (US$ Million)

Table 43. Global Alzheimer's Disease Drug Revenue Share by Application (2017-2022)

Table 44. Global Alzheimer's Disease Drug Revenue Share by Application (2023-2028)

Table 45. Alzheimer's Disease Drug Price by Application (2017-2022) & (US$/Unit)

Table 46. Global Alzheimer's Disease Drug Price Forecast by Application (2023-2028) & (US$/Unit)

Table 47. North America Alzheimer's Disease Drug Sales by Type (2017-2022) & (M Units)

Table 48. North America Alzheimer's Disease Drug Sales by Type (2023-2028) & (M Units)

Table 49. North America Alzheimer's Disease Drug Revenue by Type (2017-2022) & (US$ Million)

Table 50. North America Alzheimer's Disease Drug Revenue by Type (2023-2028) & (US$ Million)

Table 51. North America Alzheimer's Disease Drug Sales by Application (2017-2022) & (M Units)

Table 52. North America Alzheimer's Disease Drug Sales by Application (2023-2028) & (M Units)

Table 53. North America Alzheimer's Disease Drug Revenue by Application (2017-2022) & (US$ Million)

Table 54. North America Alzheimer's Disease Drug Revenue by Application (2023-2028) & (US$ Million)

Table 55. North America Alzheimer's Disease Drug Sales by Country (2017-2022) & (M Units)

Table 56. North America Alzheimer's Disease Drug Sales by Country (2023-2028) & (M Units)

Table 57. North America Alzheimer's Disease Drug Revenue by Country (2017-2022) & (US$ Million)

Table 58. North America Alzheimer's Disease Drug Revenue by Country (2023-2028) & (US$ Million)

Table 59. Europe Alzheimer's Disease Drug Sales by Type (2017-2022) & (M Units)

Table 60. Europe Alzheimer's Disease Drug Sales by Type (2023-2028) & (M Units)

Table 61. Europe Alzheimer's Disease Drug Revenue by Type (2017-2022) & (US$ Million)

Table 62. Europe Alzheimer's Disease Drug Revenue by Type (2023-2028) & (US$ Million)

Table 63. Europe Alzheimer's Disease Drug Sales by Application (2017-2022) & (M Units)

Table 64. Europe Alzheimer's Disease Drug Sales by Application (2023-2028) & (M Units)

Table 65. Europe Alzheimer's Disease Drug Revenue by Application (2017-2022) & (US$ Million)

Table 66. Europe Alzheimer's Disease Drug Revenue by Application (2023-2028) & (US$ Million)

Table 67. Europe Alzheimer's Disease Drug Sales by Country (2017-2022) & (M Units)

Table 68. Europe Alzheimer's Disease Drug Sales by Country (2023-2028) & (M Units)

Table 69. Europe Alzheimer's Disease Drug Revenue by Country (2017-2022) & (US$ Million)

Table 70. Europe Alzheimer's Disease Drug Revenue by Country (2023-2028) & (US$ Million)

Table 71. Asia Pacific Alzheimer's Disease Drug Sales by Type (2017-2022) & (M Units)

Table 72. Asia Pacific Alzheimer's Disease Drug Sales by Type (2023-2028) & (M Units)

Table 73. Asia Pacific Alzheimer's Disease Drug Revenue by Type (2017-2022) & (US$ Million)

Table 74. Asia Pacific Alzheimer's Disease Drug Revenue by Type (2023-2028) & (US$ Million)

Table 75. Asia Pacific Alzheimer's Disease Drug Sales by Application (2017-2022) & (M Units)

Table 76. Asia Pacific Alzheimer's Disease Drug Sales by Application (2023-2028) & (M Units)

Table 77. Asia Pacific Alzheimer's Disease Drug Revenue by Application (2017-2022) & (US$ Million)

Table 78. Asia Pacific Alzheimer's Disease Drug Revenue by Application (2023-2028) & (US$ Million)

Table 79. Asia Pacific Alzheimer's Disease Drug Sales by Region (2017-2022) & (M Units)

Table 80. Asia Pacific Alzheimer's Disease Drug Sales by Region (2023-2028) & (M Units)

Table 81. Asia Pacific Alzheimer's Disease Drug Revenue by Region (2017-2022) & (US$ Million)

Table 82. Asia Pacific Alzheimer's Disease Drug Revenue by Region (2023-2028) & (US$ Million)

Table 83. Latin America Alzheimer's Disease Drug Sales by Type (2017-2022) & (M Units)

Table 84. Latin America Alzheimer's Disease Drug Sales by Type (2023-2028) & (M Units)

Table 85. Latin America Alzheimer's Disease Drug Revenue by Type (2017-2022) & (US$ Million)

Table 86. Latin America Alzheimer's Disease Drug Revenue by Type (2023-2028) & (US$ Million)

Table 87. Latin America Alzheimer's Disease Drug Sales by Application (2017-2022) & (M Units)

Table 88. Latin America Alzheimer's Disease Drug Sales by Application (2023-2028) & (M Units)

Table 89. Latin America Alzheimer's Disease Drug Revenue by Application (2017-2022) & (US$ Million)

Table 90. Latin America Alzheimer's Disease Drug Revenue by Application (2023-2028) & (US$ Million)

Table 91. Latin America Alzheimer's Disease Drug Sales by Country (2017-2022) & (M Units)

Table 92. Latin America Alzheimer's Disease Drug Sales by Country (2023-2028) & (M Units)

Table 93. Latin America Alzheimer's Disease Drug Revenue by Country (2017-2022) & (US$ Million)

Table 94. Latin America Alzheimer's Disease Drug Revenue by Country (2023-2028) & (US$ Million)

Table 95. Middle East and Africa Alzheimer's Disease Drug Sales by Type (2017-2022) & (M Units)

Table 96. Middle East and Africa Alzheimer's Disease Drug Sales by Type (2023-2028) & (M Units)

Table 97. Middle East and Africa Alzheimer's Disease Drug Revenue by Type (2017-2022) & (US$ Million)

Table 98. Middle East and Africa Alzheimer's Disease Drug Revenue by Type (2023-2028) & (US$ Million)

Table 99. Middle East and Africa Alzheimer's Disease Drug Sales by Application (2017-2022) & (M Units)

Table 100. Middle East and Africa Alzheimer's Disease Drug Sales by Application (2023-2028) & (M Units)

Table 101. Middle East and Africa Alzheimer's Disease Drug Revenue by Application (2017-2022) & (US$ Million)

Table 102. Middle East and Africa Alzheimer's Disease Drug Revenue by Application (2023-2028) & (US$ Million)

Table 103. Middle East and Africa Alzheimer's Disease Drug Sales by Country (2017-2022) & (M Units)

Table 104. Middle East and Africa Alzheimer's Disease Drug Sales by Country (2023-2028) & (M Units)

Table 105. Middle East and Africa Alzheimer's Disease Drug Revenue by Country (2017-2022) & (US$ Million)

Table 106. Middle East and Africa Alzheimer's Disease Drug Revenue by Country (2023-2028) & (US$ Million)

Table 107. Allergan Corporation Information

Table 108. Allergan Description and Major Businesses

Table 109. Allergan Alzheimer's Disease Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)

Table 110. Allergan Alzheimer's Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications

Table 111. Allergan Recent Developments

Table 112. Eisai Corporation Information

Table 113. Eisai Description and Major Businesses

Table 114. Eisai Alzheimer's Disease Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)

Table 115. Eisai Alzheimer's Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications

Table 116. Eisai Recent Developments

Table 117. Novartis Corporation Information

Table 118. Novartis Description and Major Businesses

Table 119. Novartis Alzheimer's Disease Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)

Table 120. Novartis Alzheimer's Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications

Table 121. Novartis Recent Developments

Table 122. Daiichi Sankyo Corporation Information

Table 123. Daiichi Sankyo Description and Major Businesses

Table 124. Daiichi Sankyo Alzheimer's Disease Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)

Table 125. Daiichi Sankyo Alzheimer's Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications

Table 126. Daiichi Sankyo Recent Developments

Table 127. Merz Pharma Corporation Information

Table 128. Merz Pharma Description and Major Businesses

Table 129. Merz Pharma Alzheimer's Disease Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)

Table 130. Merz Pharma Alzheimer's Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications

Table 131. Merz Pharma Recent Developments

Table 132. Pfizer Corporation Information

Table 133. Pfizer Description and Major Businesses

Table 134. Pfizer Alzheimer's Disease Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)

Table 135. Pfizer Alzheimer's Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications

Table 136. Pfizer Recent Developments

Table 137. Johnson & Johnson Corporation Information

Table 138. Johnson & Johnson Description and Major Businesses

Table 139. Johnson & Johnson Alzheimer's Disease Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)

Table 140. Johnson & Johnson Alzheimer's Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications

Table 141. Johnson & Johnson Recent Developments

Table 142. Lundbeck Corporation Information

Table 143. Lundbeck Description and Major Businesses

Table 144. Lundbeck Alzheimer's Disease Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)

Table 145. Lundbeck Alzheimer's Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications

Table 146. Lundbeck Recent Developments

Table 147. Key Raw Materials Lists

Table 148. Raw Materials Key Suppliers Lists

Table 149. Alzheimer's Disease Drug Distributors List

Table 150. Alzheimer's Disease Drug Customers List

Table 151. Alzheimer's Disease Drug Market Trends

Table 152. Alzheimer's Disease Drug Market Drivers

Table 153. Alzheimer's Disease Drug Market Challenges

Table 154. Alzheimer's Disease Drug Market Restraints

Table 155. Research Programs/Design for This Report

Table 156. Key Data Information from Secondary Sources

Table 157. Key Data Information from Primary Sources

List of Figures

Figure 1. Alzheimer's Disease Drug Product Picture

Figure 3. Global Alzheimer's Disease Drug Market Share by Type in 2021 & 2028

Figure 3. Donepezil Product Picture

Figure 4. Memantine Product Picture

Figure 5. Rivastigmine Product Picture

Figure 6. Others Product Picture

Figure 7. Global Alzheimer's Disease Drug Market Share by Application in 2021 & 2028

Figure 8. Early to Moderate Stages

Figure 9. Moderate to Severe Stages

Figure 10. Alzheimer's Disease Drug Report Years Considered

Figure 11. Global Alzheimer's Disease Drug Sales 2017-2028 (M Units)

Figure 12. Global Alzheimer's Disease Drug Revenue, (US$ Million), 2017 VS 2021 VS 2028

Figure 13. Global Alzheimer's Disease Drug Revenue 2017-2028 (US$ Million)

Figure 14. Global Alzheimer's Disease Drug Revenue Market Share by Region in Percentage: 2021 Versus 2028

Figure 15. Global Alzheimer's Disease Drug Sales Market Share by Region (2017-2022)

Figure 16. Global Alzheimer's Disease Drug Sales Market Share by Region (2023-2028)

Figure 17. North America Alzheimer's Disease Drug Sales YoY (2017-2028) & (M Units)

Figure 18. North America Alzheimer's Disease Drug Revenue YoY (2017-2028) & (US$ Million)

Figure 19. Europe Alzheimer's Disease Drug Sales YoY (2017-2028) & (M Units)

Figure 20. Europe Alzheimer's Disease Drug Revenue YoY (2017-2028) & (US$ Million)

Figure 21. Asia-Pacific Alzheimer's Disease Drug Sales YoY (2017-2028) & (M Units)

Figure 22. Asia-Pacific Alzheimer's Disease Drug Revenue YoY (2017-2028) & (US$ Million)

Figure 23. Latin America Alzheimer's Disease Drug Sales YoY (2017-2028) & (M Units)

Figure 24. Latin America Alzheimer's Disease Drug Revenue YoY (2017-2028) & (US$ Million)

Figure 25. Middle East & Africa Alzheimer's Disease Drug Sales YoY (2017-2028) & (M Units)

Figure 26. Middle East & Africa Alzheimer's Disease Drug Revenue YoY (2017-2028) & (US$ Million)

Figure 27. The Alzheimer's Disease Drug Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021

Figure 28. The Top 5 and 10 Largest Manufacturers of Alzheimer's Disease Drug in the World: Market Share by Alzheimer's Disease Drug Revenue in 2021

Figure 29. Global Alzheimer's Disease Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021

Figure 30. Global Alzheimer's Disease Drug Sales Market Share by Type (2017-2028)

Figure 31. Global Alzheimer's Disease Drug Revenue Market Share by Type (2017-2028)

Figure 32. Global Alzheimer's Disease Drug Sales Market Share by Application (2017-2028)

Figure 33. Global Alzheimer's Disease Drug Revenue Market Share by Application (2017-2028)

Figure 34. North America Alzheimer's Disease Drug Sales Market Share by Type (2017-2028)

Figure 35. North America Alzheimer's Disease Drug Revenue Market Share by Type (2017-2028)

Figure 36. North America Alzheimer's Disease Drug Sales Market Share by Application (2017-2028)

Figure 37. North America Alzheimer's Disease Drug Revenue Market Share by Application (2017-2028)

Figure 38. North America Alzheimer's Disease Drug Sales Share by Country (2017-2028)

Figure 39. North America Alzheimer's Disease Drug Revenue Share by Country (2017-2028)

Figure 40. U.S. Alzheimer's Disease Drug Revenue (2017-2028) & (US$ Million)

Figure 41. Canada Alzheimer's Disease Drug Revenue (2017-2028) & (US$ Million)

Figure 42. Europe Alzheimer's Disease Drug Sales Market Share by Type (2017-2028)

Figure 43. Europe Alzheimer's Disease Drug Revenue Market Share by Type (2017-2028)

Figure 44. Europe Alzheimer's Disease Drug Sales Market Share by Application (2017-2028)

Figure 45. Europe Alzheimer's Disease Drug Revenue Market Share by Application (2017-2028)

Figure 46. Europe Alzheimer's Disease Drug Sales Share by Country (2017-2028)

Figure 47. Europe Alzheimer's Disease Drug Revenue Share by Country (2017-2028)

Figure 48. Germany Alzheimer's Disease Drug Revenue (2017-2028) & (US$ Million)

Figure 49. France Alzheimer's Disease Drug Revenue (2017-2028) & (US$ Million)

Figure 50. U.K. Alzheimer's Disease Drug Revenue (2017-2028) & (US$ Million)

Figure 51. Italy Alzheimer's Disease Drug Revenue (2017-2028) & (US$ Million)

Figure 52. Russia Alzheimer's Disease Drug Revenue (2017-2028) & (US$ Million)

Figure 53. Asia Pacific Alzheimer's Disease Drug Sales Market Share by Type (2017-2028)

Figure 54. Asia Pacific Alzheimer's Disease Drug Revenue Market Share by Type (2017-2028)

Figure 55. Asia Pacific Alzheimer's Disease Drug Sales Market Share by Application (2017-2028)

Figure 56. Asia Pacific Alzheimer's Disease Drug Revenue Market Share by Application (2017-2028)

Figure 57. Asia Pacific Alzheimer's Disease Drug Sales Share by Region (2017-2028)

Figure 58. Asia Pacific Alzheimer's Disease Drug Revenue Share by Region (2017-2028)

Figure 59. China Alzheimer's Disease Drug Revenue (2017-2028) & (US$ Million)

Figure 60. Japan Alzheimer's Disease Drug Revenue (2017-2028) & (US$ Million)

Figure 61. South Korea Alzheimer's Disease Drug Revenue (2017-2028) & (US$ Million)

Figure 62. India Alzheimer's Disease Drug Revenue (2017-2028) & (US$ Million)

Figure 63. Australia Alzheimer's Disease Drug Revenue (2017-2028) & (US$ Million)

Figure 64. China Taiwan Alzheimer's Disease Drug Revenue (2017-2028) & (US$ Million)

Figure 65. Indonesia Alzheimer's Disease Drug Revenue (2017-2028) & (US$ Million)

Figure 66. Thailand Alzheimer's Disease Drug Revenue (2017-2028) & (US$ Million)

Figure 67. Malaysia Alzheimer's Disease Drug Revenue (2017-2028) & (US$ Million)

Figure 68. Latin America Alzheimer's Disease Drug Sales Market Share by Type (2017-2028)

Figure 69. Latin America Alzheimer's Disease Drug Revenue Market Share by Type (2017-2028)

Figure 70. Latin America Alzheimer's Disease Drug Sales Market Share by Application (2017-2028)

Figure 71. Latin America Alzheimer's Disease Drug Revenue Market Share by Application (2017-2028)

Figure 72. Latin America Alzheimer's Disease Drug Sales Share by Country (2017-2028)

Figure 73. Latin America Alzheimer's Disease Drug Revenue Share by Country (2017-2028)

Figure 74. Mexico Alzheimer's Disease Drug Revenue (2017-2028) & (US$ Million)

Figure 75. Brazil Alzheimer's Disease Drug Revenue (2017-2028) & (US$ Million)

Figure 76. Argentina Alzheimer's Disease Drug Revenue (2017-2028) & (US$ Million)

Figure 77. Colombia Alzheimer's Disease Drug Revenue (2017-2028) & (US$ Million)

Figure 78. Middle East and Africa Alzheimer's Disease Drug Sales Market Share by Type (2017-2028)

Figure 79. Middle East and Africa Alzheimer's Disease Drug Revenue Market Share by Type (2017-2028)

Figure 80. Middle East and Africa Alzheimer's Disease Drug Sales Market Share by Application (2017-2028)

Figure 81. Middle East and Africa Alzheimer's Disease Drug Revenue Market Share by Application (2017-2028)

Figure 82. Middle East and Africa Alzheimer's Disease Drug Sales Share by Country (2017-2028)

Figure 83. Middle East and Africa Alzheimer's Disease Drug Revenue Share by Country (2017-2028)

Figure 84. Turkey Alzheimer's Disease Drug Revenue (2017-2028) & (US$ Million)

Figure 85. Saudi Arabia Alzheimer's Disease Drug Revenue (2017-2028) & (US$ Million)

Figure 86. UAE Alzheimer's Disease Drug Revenue (2017-2028) & (US$ Million)

Figure 87. Alzheimer's Disease Drug Value Chain

Figure 88. Alzheimer's Disease Drug Production Process

Figure 89. Channels of Distribution

Figure 90. Distributors Profiles

Figure 91. Bottom-up and Top-down Approaches for This Report

Figure 92. Data Triangulation

Figure 93. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user(purchaser of the report) to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (10% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Alzheimer's Disease Drug Market Insights and Forecast to 2028

Published Date: January 2022

Report Code: QYRE-Auto-1529

Global Alzheimer's Disease Drug Market Insights and Forecast to 2028

FEATURED COMPANIES

Segment by Type

Segment by Application

BY COMPANY

BY REGION

FEATURED COMPANIES

FEATURED COMPANIES

HAVE A QUERY?

OUR CUSTOMER

SIMILAR REPORTS

Support Contacts

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

POLICIES

THE COMPANY

CUSTOMER SUPPORT

OUR PRODUCTS

POLICES

Copyright © 2018 Valuates.com. All Rights Reserved.

Sitemap - Privacy Policy - Terms & Conditions